Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Doptelet
Pharma
Sobi acquires Dova in $915M hematology franchise play
Swedish pharma Sobi is looking for a leg up in hemotology. Can a $915 million buyout of Dova—and its so-far-underperforming drug Doptelet—do the trick?
Kyle Blankenship
Sep 30, 2019 12:03pm
Tiny Dova and its Doptelet drug take on Novartis blockbuster
Jun 28, 2019 10:25am
Salix inks deal with Dova, 3rd recent deal to boost portfolio
Oct 5, 2018 11:03am
